ConductScience.org, home

Paper · 5000992

Suppression of in vitro antigen-induced lymphocyte transformation by carrageenan, a macrophage-toxic agent.

Lake WW and 3 others. J Immunol, 1971. Cited by 88 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Suppression of in vitro antigen-induced lymphocyte transformation by carrageenan, a macrophage-toxic agent. Papers, record 5000992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5000992

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Suppression of in vitro antigen-induced lymphocyte transformation by carrageenan, a macrophage-toxic agent.
PubMed
Journal
J Immunol
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
2.41
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lake WWW W
2Bice DD
3Schwartz HJH J
4Salvaggio JJ

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarrageenanMajor topic
Lymphocyte ActivationMajor topic
MacrophagesMajor topic
Animals
Antigens
Culture Techniques
Guinea Pigs
Humans
Lectins
Lymph Nodes
Lymphocytes
Mycobacterium tuberculosis
Skin Tests
Thymidine
Tritium

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
7,085,073Chemotaxis of purified human monocytes in vitro: lack of accessory cell requirement.Infect Immun1982https://conductscience.org/library/papers/7085073PubMed
6,721,577Effect of macrophages on elimination of dermal melanin from the dermis.Arch Dermatol Res1984https://conductscience.org/library/papers/6721577PubMed
6,613,749Desulfated carrageenans and cytotoxicity of human monocytes.Agents Actions1983https://conductscience.org/library/papers/6613749PubMed
6,447,112In vitro suppression of T-cell mitogenic response and tumor cell proliferation by spleen macrophages from normal chickens.Infect Immun1980https://conductscience.org/library/papers/6447112PubMed
6,245,672Selective macrophage inhibition abolishes warfarin-induced reduction of metastasis.Br J Cancer1980https://conductscience.org/library/papers/6245672PubMed
4,559,193The effects of mercaptoethanol and of peritoneal macrophages on the antibody-forming capacity of nonadherent mouse spleen cells in vitro.J Exp Med1972https://conductscience.org/library/papers/4559193PubMed
4,546,490The cellular origin of the lymphochte trap.Immunology1974https://conductscience.org/library/papers/4546490PubMed
4,138,693Macrophage-lymphocyte clusters in the immune response to soluble protein antigen in vitro.J Exp Med1974https://conductscience.org/library/papers/4138693PubMed
3,965,392Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii.Infect Immun1985https://conductscience.org/library/papers/3965392PubMed
3,845,850Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes.Cancer Immunol Immunother1985https://conductscience.org/library/papers/3845850PubMed

1 to 10 of 15

See all 15 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5000992

GET https://conductscience.org/api/papers/v1/5000992/authors